Squamous cell carcinoma ofthe larynx in children is rare. The management of laryngeal malignancy is more difficult in children than adults for several reasons: the aggressive nature ofa tumor that is often diagnosed late in children; the delicacy of pediatric anatomic stru ctures; intraoperative blo od loss ; long-term post-treatment complications; and psychological factors pa rticular to children. A trach eostomized 13-year-old boy came to us with a 4-month history ofhoarsen ess, breathing diffi culty, and swelling in the neck. A detailed examination rev ealed that a transglottic tumor had infiltrated the thyroid and cricoid cartilage, the upper two tra cheal rings, and the thyroid gland. Such an infiltration has not been previously repo rted. The lesion proved to be a well-differentiated squamous cell carcinoma. We performed a widefield total laryngectomy, whi ch was f ollowed by radiotherapy. Unfortunately, the child survived only 3 years postoperatively.
Introduction
Head and neck malignancy is more common in adults than in children. Nevertheless, physicians must be aware that a small percentage of cases does occur in the pediatric age group. The first reported case of squamous cell carcinoma in a child was published in 1868 by Rehn (the patient was a 3-year-old boy).' Since then , 57 other cases have been reported .' In this article, we report a new case of pediatric squamous cell carcinoma, which was treated with surgery and radiotherapy .
Case report
A tracheostomized 13-year-old boy came to us with a 4-month history of hoarseness, breathing difficulty , and swelling in the neck. The patient had earlier undergone tracheostomy for stridor. Thereafter, he had undergone direct laryngoscopy and biopsy at another center; his- Our examination revealed that the lumen of the patient' s metal tracheostomy tube was compromised by a tumor mass. Indirect laryngoscopy identified the growth as a smooth, pink , exophytic mass, which was located below the level of the epiglottis and which cove red the entire glottis and supraglottis. On inspection and palpation of the neck, a diffuse, hard , tender, 5 x 6-cm area of swelling was noted in the front (figure I). The lesion involved the thyroid and cricoid cartilage, the upper two tracheal rings , and both lobes of the thyroid gland. No neck nodes were palpable.
We made a clinical diagnosis of a transglottic malignancy . The tumor was staged as a T4 NO MX stage IV malignancy. A lateral neck x-ray detected a soft-tissue mass that involved the larynx and trachea and extended from the C3-C7 vertebral bodies. On direct laryngopharyngoscopy unde r gene ral anesthesia, a large smooth mass in the supraglottic region could be seen obscuring the inlet of the larynx. Both the pyriform fossa and the postcricoid region were norm al. The mass bled on touch. Histopathologic examination of a biopsy specimen identified a well-differentiated squamous cell carcinoma.
After receiving motivational counseling, the patient was taken for surgery under general anesthesia. A widefield total laryngectomy with a total thyroidectomy and removal of the upper three trache al rings was performed (figure 2). A drain was inserted and the wound was closed (figure 3). Examination of the excised specimen showed that a transglottic tumor had involv ed the upper two tracheal cartilages, the laryngeal cartilage, and the thyroid gland ( figure 4 ) . Histopathologic examination again identified a squamous cell carcinom a (figure 5). The patient was put on thyroxine and calcium, and he was discharged on postope rative day 15 (figure 6). Two months later, he received 6,000 cGy of radiotherapy. Although the boy stopped attending school, he did learn esophageal speech . Unfo rtunately, he died 3 years postoperatively as the result of a local recurrence. A dra in is inserted and the wound is closed. 510 childre n, it is most commo n in those age d II to 15 yea rs, followed by those aged 6 to 10 years; it is lea st common in children aged I to 5 ye ars. 1. 3 In adults, 90 % of cases affect men; in children, the ma le-to-female ratio is 3:2.1-3
Discussion
It has been no ted th at squamous cell carcinoma is the most common type of malignancy see n in children,"? Mucoepidermoid carcin om a, rhabdom yosarcoma, and non-Hodgki n' s lymphom a have also been reported in children.>'
Predisposingfactors. An extensive review of the literature indi cated that the principal predi sposin g fact or for lar yng eal carcinoma is irr adiation of beni gn head and neck lesion s, particularly juvenile laryn ge al papillomas." Other kn own risk factors include ac tive and passive smoking, expos ure to certain chemica l agents (e .g., asbe stos ), and a family hist ory of malign ant tumors. Immunodeficien cy can impair the co ntrol of human papillomaviru s (HPV) infec tion, and co infec tion with HPV 18 and HPV 33 is not uncommon in cases of lar yn geal cancer.'
Diagnosis. Wh en they see k treatment, most affected childre n ha ve an upp er airw ay ob stru cti on , hoarseness, cou gh , and dyspnea. Th e co rrec t diagn osis of a laryn geal carcin om a is largely dep endent on a high index of suspicion when interpreting these symptoms. Th e close clinical resemblance of thi s disease to more common and ben ign childhoo d condition s often leads to diagnostic and therapeutic delays. For exa mple, diagn osis can be dela yed when sy mptoms are attr ibuted to no rm al pubertal voca l ch anges or upper res pira tory tract infections.'
Most affec ted children do not have neck node s; those wh o do ca n be mi sdi agn osed as havin g inflammatory cervica l lymphadenopath y. McGuirt and Little reported one case in which a child developed a ce rv ical metastasis.'
Our pati ent did not have a neck met asta sis. Rather, the tumor had infiltrated the thyroid and cricoid cartilage, the upper tw o tracheal rin gs, and the thyroid gl and. Such an infiltrati on has not been previ ou sly rep orted . The tum or ' s invasion of the trach eostom a was bl am ed on the cons iderable delay in the diagn osis of the mali gn ancy. In ea rlier rep orted ca ses, the principal site of or igi n was the vocal folds; othe r sites we re the suprag lottic and subglottic regi on s. Our patient had a tran sglottic mali gn anc y.
To avo id any delay in diagnosis, it is advisabl e to examin e any child with a suspected malignanc y by dire ct laryngoscopy (rig id or flexible) under gene ral anesthes ia and to obtain a biopsy analys is of any suspicious lesion . Radi ographic studies of the bone , liv er , and splee n and abd ominal ultra son ogr aph y ca n also be perform ed to search for me tas tas is. Computed tomogr aph y and magneti c reson ance im agin g ca n ass ist in stagi ng, and they are also help ful in followin g the res ponse to therap y.'> Treatment. Th e ex tent of treatment dep end s on the tum or ' s stage, the pre sen ce or ab sen ce of laryngeal cartilage involv em ent, and the pre sence or abse nce of metastasis. Prese rvation of laryngeal function is a primary con - 
Getting Started
The test kit comes with everything you need to perform the brush biopsy. 
Site prior to brush biopsy
Site after brush biopsy
Preparing the Specimen
Spread the cellular sample from the brush onto the glass slide. Rotate and drag the brush lengthwise, transferr ing as much material as possible .
Fixative
Quickly squeeze the entire contents of one fixative package onto the glass slide, flooding the slide. Set the slide aside to dry for 15 minutes, then place it in the slide holder.
After completing the test requisition form, you are ready to send the specimen to OralScan Laboratories in the postage-paid box provided.
Results
Surgeons are faxed an OralCDx report usually within 3 days after the specimen is received by the laboratory. For lesions with "positive" or "atypical" OralCDx results, a summary screen conta ining representative cellular abnormalities is printed (pictured left), and together with a pathologist's explanatory report, is mailed to the surgeon. These images enable the surgeon to explain the abnormal test results to the patient, and substantiate the need for further evaluation of the lesion.
The Cornputer-Assisted, Brush Biopsy Test for the Early Detection of Oral Cancer
What is e accuracy of OralCDx?
In the U.S., a multicenter clinical trial of close to 1000 patients was conducted at 35academic centers using OraiCOx. The outcome showed OralCOx to bevery precise -independently detecting 100% of histologically confirmed oral precancer and cancer (statistically significant sensitivity> 96%, p <.05, n=131). Furthermore, OralCOx uncovered precancer or cancer among 4.5% of clinically benignappearing lesions that would nothave received additional testing or attention other than clinical follow up, and which were judged harmless in appearance byexperienced academicians. The complete study was published asthe cover article of the October, 1999 issue of The Journal of the American Dental Association.
Q. Why is the surgeon's procedure "fail-safe"?
A. Each specimen arriving at OralScan Laboratories is automatically evaluated byboth the computer system and the specialty pathologist to determine thatthe biopsy brush has penetrated to the basement membrane. This is achieved byverification thatcells from all three layers of the epithelium have been obtained. This key feature makes the brush biopsy procedure "confirmable" or "fail-safe" in that it assures the surgeon thata complete, full-thickness, transepithelial biopsy specimen has been obtained. Inthose infrequent instances when the sample obtained bythe surgeon is nota full-thickness, transepithelial biopsy (Which may occur, for example, if insufficient pressure is applied or if the brush is notrotated a sufficient number of times), this cannot result in testerror. Instead the surgeon will be informed thatthe sample was inadequate for analysis. The brush biopsy should then be repeated at nocharge to the patient. The laboratory also does notcharge for analysis of such repeat specimens.
Q. How is the brush biopsy sample analyzed?
A. ' In addition to the pathologist's manual microscopic analysis, each brush biopsy specimen is scanned bythe OralCOx computer. This consists of a neural-network-based, image-processing system, specifically designed to detect oral epithelial precancerous and cancerous cells. The core technology behind the OralCOx computer was originally developed for the SOl missile defense system. It searches the brush biopsy specimen for a combination of abnormal cellular morphology and abnormal keratinization, which uniquely characterizes dysplasia and carcinoma of the oral epithelium. This image analysis process is performed utilizing a specially designed image processor that has been demonstrated to detect asfew astwo abnormal oral epithelial cells scattered among more than one hundred thousand normal cells typically distributed oneach oral brush biopsy specimen.
Q. What does the OralCDx test costthe patient?
A. The patient incurs two fees, one for the brush biopsy procedure and the second for the laboratory analysis of thespecimen.
The first charge the patient incurs is the surgeon's fee for performing the brush biopsy procedure. Insurance, including Medicare, will typically reimburse for the biopsy procedure. CPT codes available to report this procedure are supplied with the OralCOx kits.
The second charge the patient incurs is for laboratory analysis of the brush biopsy. OralScan Laboratories will file a claim with the patient's insurance for its laboratory analysis fee. Like the brush biopsy procedure, this fee is also typically reimbursed byinsurance including Medicare.
Q. How can I get test kits?
A. Call Toll-Free 1-877-ORALSCAN (1 -877-672-5722) or email to oralcdx@oralscan.com for an introductory package which contains 4 test kits.
Note: All of the lesions pictured on the first page were determined to be either precancer or cancer.
OralScan Laboratories Two Executive Boulevard
Suffern , NY 10901
Phone: 845-369-7096 • Fax: 845-369-7082 oralcdx@oralscan.com sideration. The use of surgery, radiotherapy, and chem otherapy-alone and in various combin ation s-has been described by various authors. However, successful managem ent and the attainment of good long-t erm outc omes are hindered by several problems relating to the operative procedure, blood loss, complications, and certain psychological factors : Operativeprocedure. Laryngectomy in children is more difficult than in adults bec ause a child ' s structures are more delicate and the working space is limited.
Blood loss. The amount of blood loss in a child relat ive to body weight is an import ant consideration, and rigorous attention should be paid to minimizin g it.
Compli cations. Children who undergo radiotherapy encounter more compl ications than do adult s, primaril y because they live so much longer followin g treatm ent.' The surgeon must anticipate that the growth of irradiated structures might be arrested , that abnormalities might occur in the patient' s offspring, and that the patient might develop a secondary neopla sm.
Psychological aspects. It is most difficult to explain to young patient s the nature of their disease, the type of operation that is going to be performed, and its aftereffects.
Once a tumor invol ves the cartilages of the laryn x and thyroid, surgery and postope rati ve irradi ation is the treatment of choice. Malignancies of the larynx are more aggressive in children than in adults, prob ably because they are recognized at a later stage. As a result, many affected children have a poor prognosis. Because of the scarcity of reports in the literature, we have no definitive information on optional treatm ent protocol s.
